Martorano 2016 Abstract Mito Xmas Meeting Innsbruck: Difference between revisions

From Bioblast
(Created page with "{{Abstract |title= |authors= |year=2016 |event=Mito Xmas Meeting 2016 Innsbruck AT |abstract= }} {{Labeling }} == Affiliations == :::: ::::#")
 
No edit summary
Line 1: Line 1:
{{Abstract
{{Abstract
|title=
|title=OXPHOS complex impairment and mitochondrial DNA depletion modify Hypoxia signaling pathway activity in zebrafish.
|authors=
 
|authors=Martorano L, Tiso N, Busolin G, Ek O, Facchinello N, Vanzi F, Vettori A, Argenton F
|year=2016
|year=2016
|event=Mito Xmas Meeting 2016 Innsbruck AT
|event=Mito Xmas Meeting 2016 Innsbruck AT
|abstract=
|abstract=Mitochondria are essential for cell survival and health, utilizing about 90% of the oxygen we breath for OXPHOS. Previous studies showed a strong relationship between mitochondrial alterations and hypoxia signaling pathway, an interesting aspect to be investigated. POLG-related disorders are a group of diseases characterized by the dysfunction of DNA polymerase gamma, an enzyme crucial for mtDNA replication, repair and stability. Danio rerio (zebrafish) is an ideal vertebrate model of human mitochondrial diseases because of its high conservation of physiological processes and genomic structure, transgenic lines availability and embryonic transparency. Using zebrafish embryos, we have performed a transient knock-down of the polg gene, inducing a dilated cardiomyopathy and an increased heart bit rate. Moreover, we have developed a transgenic line able to show in vivo the activation of hypoxia-inducible factor 1 (Hif1) signaling. Taking advantage of this reporter line, we established that Hypoxia pathway is up-regulated in polg morphants. In addition, using a pharmacological approach targeting OXPHOS complexes NADH:ubiquinone reductase (Complex I) and Succinate dehydrogenase (Complex II), we have investigated the effect of mitochondrial dysfunctions on the Hypoxia pathway. We established that Hypoxia pathway is significantly reduced, both in normoxia and in hypoxia conditions, perhaps due to an increase in ROS production. In conclusion, our data suggest the existence of cross-talk mechanisms sensing mitochondrial dysfunction and changing Hypoxia signaling. In addition, our results on polg transient inactivation incourage the use of zebrafish as a suitable model to perform CRISPR/Cas9-mediated mutagenesis of DNA polymerase gamma, an ongoing project in our laboratory.
 
 


}}
}}
{{Labeling
{{Labeling
|event=Poster
}}
}}
== Affiliations ==
== Affiliations ==


::::  
:::: Martorano L(1), Tiso N(1), Busolin G(1), Ek O(1), Facchinello N(1), Vanzi F(2), Vettori A(1), Argenton F(1)


::::#
::::# Dept Biology, Univ Padua, Italy
::::# Dept Biology, Univ Florence, Italy

Revision as of 12:15, 7 December 2016

OXPHOS complex impairment and mitochondrial DNA depletion modify Hypoxia signaling pathway activity in zebrafish.

Link:

Martorano L, Tiso N, Busolin G, Ek O, Facchinello N, Vanzi F, Vettori A, Argenton F (2016)

Event: Mito Xmas Meeting 2016 Innsbruck AT

Mitochondria are essential for cell survival and health, utilizing about 90% of the oxygen we breath for OXPHOS. Previous studies showed a strong relationship between mitochondrial alterations and hypoxia signaling pathway, an interesting aspect to be investigated. POLG-related disorders are a group of diseases characterized by the dysfunction of DNA polymerase gamma, an enzyme crucial for mtDNA replication, repair and stability. Danio rerio (zebrafish) is an ideal vertebrate model of human mitochondrial diseases because of its high conservation of physiological processes and genomic structure, transgenic lines availability and embryonic transparency. Using zebrafish embryos, we have performed a transient knock-down of the polg gene, inducing a dilated cardiomyopathy and an increased heart bit rate. Moreover, we have developed a transgenic line able to show in vivo the activation of hypoxia-inducible factor 1 (Hif1) signaling. Taking advantage of this reporter line, we established that Hypoxia pathway is up-regulated in polg morphants. In addition, using a pharmacological approach targeting OXPHOS complexes NADH:ubiquinone reductase (Complex I) and Succinate dehydrogenase (Complex II), we have investigated the effect of mitochondrial dysfunctions on the Hypoxia pathway. We established that Hypoxia pathway is significantly reduced, both in normoxia and in hypoxia conditions, perhaps due to an increase in ROS production. In conclusion, our data suggest the existence of cross-talk mechanisms sensing mitochondrial dysfunction and changing Hypoxia signaling. In addition, our results on polg transient inactivation incourage the use of zebrafish as a suitable model to perform CRISPR/Cas9-mediated mutagenesis of DNA polymerase gamma, an ongoing project in our laboratory.


Labels:






Event: Poster 


Affiliations

Martorano L(1), Tiso N(1), Busolin G(1), Ek O(1), Facchinello N(1), Vanzi F(2), Vettori A(1), Argenton F(1)
  1. Dept Biology, Univ Padua, Italy
  2. Dept Biology, Univ Florence, Italy
Cookies help us deliver our services. By using our services, you agree to our use of cookies.